Last Updated: May 10, 2026

Suppliers and packagers for STRIVERDI RESPIMAT


✉ Email this page to a colleague

« Back to Dashboard


STRIVERDI RESPIMAT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Boehringer Ingelheim STRIVERDI RESPIMAT olodaterol hydrochloride SPRAY, METERED;INHALATION 203108 NDA Boehringer Ingelheim Pharmaceuticals, Inc. 0597-0192-61 1 CARTRIDGE in 1 CARTON (0597-0192-61) / 60 SPRAY, METERED in 1 CARTRIDGE 2014-08-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for STRIVERDI RESPIMAT

Last updated: April 25, 2026

Who Supplies STRIVERDI RESPIMAT? (Brand, Marketer, and Likely Drug-Substance and Device Chain)

STRIVERDI RESPIMAT is a marketed inhalation product in the U.S. containing olodaterol (long-acting beta2-agonist). The supply chain for a marketed inhalation product typically splits into three layers: (1) drug substance and drug product manufacturing, (2) inhaler device manufacturing and assembly, and (3) finished-product release/distribution by the U.S. marketer.

However, no complete supplier roster (by company name) is present in the prompt. A supplier list that names specific manufacturers for olodaterol drug substance, inhaler/device components, contract manufacturing, and final release entities requires product-label “Manufactured for/By” and/or FDA registration and commercial supply data. With only the product name provided, a complete and accurate supplier mapping cannot be produced.

What can be stated from the product identity alone

  • Drug class and active: STRIVERDI RESPIMAT is an inhaled olodaterol product.
  • Delivery system: RESPIMAT indicates a Soft Mist inhaler platform; the device requires specialized manufacturing and assembly.
  • Supply-chain structure: expect separate entities for olodaterol manufacturing, finished dose fill and assembly, and device/valve-and-cartridge supply.

STRIVERDI RESPIMAT supplier roster: unavailable from the provided inputs

A legally actionable supplier list for:

  • olodaterol drug substance supplier(s) (API manufacturer(s)),
  • finished-dose manufacturer(s) (contract or internal),
  • inhaler device manufacturer(s) and cartridge/valve supplier(s),
  • U.S. NDA/ANDA labeler and distributor, and
  • batch release site(s)

requires source artifacts such as the U.S. label “Manufactured for” section and/or FDA establishment-registration and listing records for the exact dosage form and strength.

Key Takeaways

  • STRIVERDI RESPIMAT is an olodaterol inhalation product delivered via the RESPIMAT Soft Mist platform.
  • A definitive, company-by-company supplier list cannot be produced from the product name alone without label- or registry-level evidence.

FAQs

  1. Who is the manufacturer of STRIVERDI RESPIMAT in the U.S.?
    Not determinable from the prompt alone.

  2. Who supplies the RESPIMAT device components?
    Not determinable from the prompt alone.

  3. Who supplies olodaterol (the API) used in STRIVERDI RESPIMAT?
    Not determinable from the prompt alone.

  4. Is the supply chain centralized or split across contract manufacturing and device assembly?
    Inhalation products typically split across drug substance, drug product fill, and device assembly, but exact entities are not provided in the prompt.

  5. Where can the “Manufactured for/By” supplier names be verified?
    In the product label and FDA listing/registration records, but those sources are not supplied in the prompt.

References

No sources were provided in the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.